Log in

ICMRS Scientific Frontier Webinar Series: Dr. Ling Qin, Chinese University of Hong Kong

  • 29 Aug 2020
  • 9:00 PM (EDT)

ICMRS Scientific Frontier Webinar Series

A Platform for Publishing Translational Research in ICMRS Society Journal JOT

Presented by Ling Qin, Ph.D.

Professor and Director, Musculoskeletal Research Laboratory

Chinese University of Hong Kong

When: August 29, 2020 (Saturday) 9:00 PM Eastern Time (US and Canada)

August 29, 2020 (Saturday) 8:00 PM Central Time (US and Canada)

2020830日(星期日)北京时间上午9:00 (中国)

August 30, 2020 (Sunday) 9:00 AM Perth (Australia - Western Australia)

August 30, 2020 (Sunday) 11:00 AM Sydney (Australia - New South Wales)

Where: click here to view the recorded webinar.

Short Biography: Dr. Ling Qin is Professor and Director of Musculoskeletal Research Laboratory in the Department of Orthopaedics & Traumatology and director of a newly established Hong Kong – Shenzhen Innovation and Technology Research Institute of the Chinese University of Hong Kong. Dr. Qin also holds joint professorship in Shenzhen Institutes of Advance Technology (SIAT) of Chinese Academy of Sciences (CAS) and serves director of the Translational Medicine Research & Development Center in SIAT. Dr. Qin focuses on translation research in R&D of innovative biomaterials and drugs for prevention and treatment of challenging bone metabolic disorders and injuries. Dr. Qin published more than 300 SCI papers and 9 monographs, with an H index of 54. Dr. Qin is editor-in-chief of Journal of Orthopaedic Translation and fellow of several leading professional; societies, including AIMBE, ICORS, ASBMR, and IUSBSE.

Abstract: The Journal of Orthopaedic Translation (JOT) is an international SCI journal focusing on orthopaedic translational medicine. JOT is a peer-reviewed, open access journal of the Chinese Speaking Orthopaedic Society (CSOS) and the International Chinese Musculoskeletal Research Society (ICMRS), established in later 2013. It is published now bimonthly by Elsevier (https://www.journals.elsevier.com/journal-of-orthopaedic-translation).

After getting its first IF 2.063 in 2018, we are pleased to have our 2019 SCI impact factor (IF) of 3.986, ranking top 10% in Q1 of JRC under the subject area of Orthoapedics and Sports Medicine. 

The Editor-in-Chief of Prof. Ling QIN (Hong Kong), past president of ICMRS, will update with members on the recent progress of JOT and performance of indices, and future development. More importantly, he will introduce the presentation format of translational research work that will help members to prepare their potential submissions effectively for the JOT , including: 1) formulation of research questions or study objectives; 2) study design with positive control whenever possible; 3) the use of established testing methods such as ISO and/or ASMT whenever possible; 4) for the development of discussions to relate major findings relative to the a study’s hypothesis and objectives, as well as obstacles in translating research findings into application.

A Q/A session will be arranged with presence of JOT associate editors who are current or past presidents or senior members of ICMRS, including Profs. Gang Li, Tingting Tang, Di Chen, and Ling Qin (USA).

This webinar will be moderated by Dr. Tingting Tang, Professor, Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital and Shanghai Jiaotong University School of Medicine.

If you are not able to attend ICMRS webinars, you are welcome to click here for recorded videos from ICMRS Scientific Frontier Webinar Series.

For more information, please contact:

Jean Jiang, PhD

Chair, Education Committee, ICMRS

Professor and Zachry Distinguished University Chair

Department of Biochemistry and Structural Biology

University of Texas Health Science Center at San Antonio

Email: icmrs@icmrs.net

Powered by Wild Apricot Membership Software